Patient Time Requirements for Anticoagulation Therapy with Warfarin
Identifieur interne : 002930 ( Ncbi/Curation ); précédent : 002929; suivant : 002931Patient Time Requirements for Anticoagulation Therapy with Warfarin
Auteurs : Daniel E. Jonas [États-Unis] ; Betsy Bryant Shilliday [États-Unis] ; W. Russell Laundon [États-Unis] ; Michael Pignone [États-Unis]Source :
- Medical decision making : an international journal of the Society for Medical Decision Making [ 0272-989X ] ; 2009.
Abstract
Most patients receiving warfarin are man- aged in outpatient office settings or anticoagulation clinics that require frequent visits for monitoring.
To measure the amount and value of time required of patients for chronic anticoagulation therapy with warfarin.
Prospective observation of a cohort of adult patients treated at a university-based anticoagulation program.
Participants completed a questionnaire and a prospective diary of the time required for 1 visit to the anticoagulation clinic, including travel, waiting, and the clinic visit. The authors reviewed subjects’ medical records to obtain additional information, including the frequency of visits to the anti- coagulation clinic. They used the human capital method to estimate the value of time.
Eighty-five subjects completed the study. The mean (median) total time per visit was 147 minutes (123). Subjects averaged 15 visits per year (14) and spent 39.0 hours (29.3) per year on their visits. Other anticoagulation-related activities, such as communication with providers, pharmacy trips, and extra time preparing food, added an average of 52.7 hours (19.0) per year. The mean annual value of patient time spent traveling, waiting, and attending anticoagulation visits was $707 (median $591). The mean annual value when also including other anticoagulation-related activities was $1799 (median $1132).
The time required of patients for anticoagulation visits was considerable, averaging approximately 2.5 hours per visit and almost 40 hours per year. Methods for reducing patient time requirements, such as home-based testing, could reduce costs for patients, employers, and companions.
Url:
DOI: 10.1177/0272989X09343960
PubMed: 19773584
PubMed Central: 4181607
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002717
- to stream Pmc, to step Curation: Pour aller vers cette notice dans l'étape Curation :002717
- to stream Pmc, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :002525
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :002930
Links to Exploration step
PMC:4181607Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Patient Time Requirements for Anticoagulation Therapy with Warfarin</title>
<author><name sortKey="Jonas, Daniel E" sort="Jonas, Daniel E" uniqKey="Jonas D" first="Daniel E." last="Jonas">Daniel E. Jonas</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Medicine, University of North Carolina, Chapel Hill, NC</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Department of Medicine, University of North Carolina, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Shilliday, Betsy Bryant" sort="Shilliday, Betsy Bryant" uniqKey="Shilliday B" first="Betsy Bryant" last="Shilliday">Betsy Bryant Shilliday</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Medicine, University of North Carolina, Chapel Hill, NC</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Department of Medicine, University of North Carolina, Chapel Hill</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A2">School of Pharmacy, University of North Carolina, Chapel Hill, NC</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>School of Pharmacy, University of North Carolina, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Laundon, W Russell" sort="Laundon, W Russell" uniqKey="Laundon W" first="W. Russell" last="Laundon">W. Russell Laundon</name>
<affiliation wicri:level="2"><nlm:aff id="A2">School of Pharmacy, University of North Carolina, Chapel Hill, NC</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>School of Pharmacy, University of North Carolina, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Pignone, Michael" sort="Pignone, Michael" uniqKey="Pignone M" first="Michael" last="Pignone">Michael Pignone</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Medicine, University of North Carolina, Chapel Hill, NC</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Department of Medicine, University of North Carolina, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">19773584</idno>
<idno type="pmc">4181607</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181607</idno>
<idno type="RBID">PMC:4181607</idno>
<idno type="doi">10.1177/0272989X09343960</idno>
<date when="2009">2009</date>
<idno type="wicri:Area/Pmc/Corpus">002717</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002717</idno>
<idno type="wicri:Area/Pmc/Curation">002717</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002717</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002525</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002525</idno>
<idno type="wicri:Area/Ncbi/Merge">002930</idno>
<idno type="wicri:Area/Ncbi/Curation">002930</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Patient Time Requirements for Anticoagulation Therapy with Warfarin</title>
<author><name sortKey="Jonas, Daniel E" sort="Jonas, Daniel E" uniqKey="Jonas D" first="Daniel E." last="Jonas">Daniel E. Jonas</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Medicine, University of North Carolina, Chapel Hill, NC</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Department of Medicine, University of North Carolina, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Shilliday, Betsy Bryant" sort="Shilliday, Betsy Bryant" uniqKey="Shilliday B" first="Betsy Bryant" last="Shilliday">Betsy Bryant Shilliday</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Medicine, University of North Carolina, Chapel Hill, NC</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Department of Medicine, University of North Carolina, Chapel Hill</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A2">School of Pharmacy, University of North Carolina, Chapel Hill, NC</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>School of Pharmacy, University of North Carolina, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Laundon, W Russell" sort="Laundon, W Russell" uniqKey="Laundon W" first="W. Russell" last="Laundon">W. Russell Laundon</name>
<affiliation wicri:level="2"><nlm:aff id="A2">School of Pharmacy, University of North Carolina, Chapel Hill, NC</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>School of Pharmacy, University of North Carolina, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Pignone, Michael" sort="Pignone, Michael" uniqKey="Pignone M" first="Michael" last="Pignone">Michael Pignone</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Department of Medicine, University of North Carolina, Chapel Hill, NC</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Department of Medicine, University of North Carolina, Chapel Hill</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Medical decision making : an international journal of the Society for Medical Decision Making</title>
<idno type="ISSN">0272-989X</idno>
<idno type="eISSN">1552-681X</idno>
<imprint><date when="2009">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Background</title>
<p id="P1">Most patients receiving warfarin are man- aged in outpatient office settings or anticoagulation clinics that require frequent visits for monitoring.</p>
</sec>
<sec id="S2"><title>Objective</title>
<p id="P2">To measure the amount and value of time required of patients for chronic anticoagulation therapy with warfarin.</p>
</sec>
<sec id="S3"><title>Design/Participants</title>
<p id="P3">Prospective observation of a cohort of adult patients treated at a university-based anticoagulation program.</p>
</sec>
<sec id="S4"><title>Measurements</title>
<p id="P4">Participants completed a questionnaire and a prospective diary of the time required for 1 visit to the anticoagulation clinic, including travel, waiting, and the clinic visit. The authors reviewed subjects’ medical records to obtain additional information, including the frequency of visits to the anti- coagulation clinic. They used the human capital method to estimate the value of time.</p>
</sec>
<sec id="S5"><title>Results</title>
<p id="P5">Eighty-five subjects completed the study. The mean (median) total time per visit was 147 minutes (123). Subjects averaged 15 visits per year (14) and spent 39.0 hours (29.3) per year on their visits. Other anticoagulation-related activities, such as communication with providers, pharmacy trips, and extra time preparing food, added an average of 52.7 hours (19.0) per year. The mean annual value of patient time spent traveling, waiting, and attending anticoagulation visits was $707 (median $591). The mean annual value when also including other anticoagulation-related activities was $1799 (median $1132).</p>
</sec>
<sec id="S6"><title>Conclusions</title>
<p id="P6">The time required of patients for anticoagulation visits was considerable, averaging approximately 2.5 hours per visit and almost 40 hours per year. Methods for reducing patient time requirements, such as home-based testing, could reduce costs for patients, employers, and companions.</p>
</sec>
</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002930 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 002930 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Ncbi |étape= Curation |type= RBID |clé= PMC:4181607 |texte= Patient Time Requirements for Anticoagulation Therapy with Warfarin }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:19773584" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a EdenteV2
This area was generated with Dilib version V0.6.32. |